Berkshire Hathaway (BRK) shares are exhibiting bearish technical signals, trading below their 200-day moving average for six weeks and declining 11% since the May announcement of Warren Buffett's 2025 CEO departure, though still up 6% YTD. This technical juncture occurs amidst significant Q2 portfolio reallocations, including a new $1.6 billion stake in UnitedHealth, increased exposure to homebuilders like Lennar and D.R. Horton, and additions to Chevron, while trimming Apple and Bank of America holdings and exiting T-Mobile. The stock's ability to decisively close above its 200-day MA is crucial for trend resumption, highlighting a strategic portfolio tilt towards healthcare, energy, and housing sectors.
Berkshire Hathaway (BRK.B) is at a critical technical juncture, characterized by bearish signals and sustained selling pressure. The stock has traded below its 200-day moving average for six consecutive weeks, its longest such period in three years, and has declined approximately 11% since the May announcement of Warren Buffett's planned CEO transition in 2025. Despite this, the stock remains up nearly 6% year-to-date. This technical weakness coincides with a significant second-quarter portfolio repositioning. The firm initiated a new $1.6 billion stake in UnitedHealth and substantially increased its exposure to the housing sector through a new position in D.R. Horton and a significant addition to its Lennar holdings. Concurrently, Berkshire trimmed its positions in major holdings like Apple and Bank of America, added to its Chevron stake, and fully exited T-Mobile. This strategic pivot towards healthcare, housing, and energy suggests a recalibration of its portfolio while the stock price consolidates, making its ability to reclaim the 200-day moving average a key catalyst for its future direction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment